News
Sunlenca is approved for patients with HIV whose infections ... real challenges with our traditional medication system.” The drug would cost $42,250 to start the therapy, and then $39,000 ...
Most traditional vaccines use a dead or weakened ... This allows them to answer many questions about the drugs. If an HIV treatment doesn't work for you, or you find your medication regimen ...
Dolutegravir plus lamivudine demonstrates noninferiority to the standard-of-care three-drug regimen in treatment-naive patients with HIV without preliminary drug resistance testing. Researchers ...
£5 allows us to reach millions of people globally with accurate and reliable resources about HIV prevention and treatment ... herbal or traditional medicines, and recreational drugs. Older age and ...
By bolstering immune cells, researchers at ViiV Healthcare in Branford have designed long-acting drugs that prevent infection ...
These results support doravirine / islatravir as an alternative to traditional multi-drug regimens, offering a simplified option for people with HIV who have no history of treatment failure or ...
Identifying HIV cases is the first step in addressing clusters, and quickly learning one’s status allows people to rapidly seek both treatment and prevention. Unlike traditional laboratory-based ...
A new study provides strong evidence supporting the use of dolutegravir and TAF-emtricitabine for second-line antiretroviral ...
Once a death sentence, human immunodeficiency virus (HIV) can now be managed with antiretroviral therapy (ART) drugs. This treatment suppresses the virus to undetectable levels, which in turn ...
Medicare beneficiaries living with HIV are covered for treatment under Original Medicare (parts A and B), Medicare Advantage, and prescription drug plans. In this article, we explore the details ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results